The manufacturers of those two drugs, Novo Nordisk and Eli Lilly, respectively, have responded by creating secondary sales channels, outside of insurance, offering cash prices that are dramatically discounted from the list price that is used as the starting point for negotiation with insurance companies
Furthermore, GLP-1 analogs may restore insulin secretion by activating the GLP-1 receptor (GLP-1R)-Gs signals because GLP-1 analogs overcome SSTR5-Gi signals in pancreatic -cells under the condition of suppressed insulin production and spare suppressed incretin secretion from intestinal L-cells 27
When activated, AMPK may enhance insulin sensitivity, increase glucose uptake in skeletal muscle, suppress hepatic gluconeogenesis, and improve lipid metabolism
Clinical trials report average reductions of over 20% of body weight over 72 weeks
Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable
However, both medications influence metabolic rate, body composition, and appetite signaling in ways that can compound or offset one another
